These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7271267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Preparation of an influenza vaccine from allantoic viral cultures inactivated with UV irradiation].
    Polianskaia NIu.
    Tr Inst Im Pastera; 1979; 52():107-10. PubMed ID: 550532
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH, Seo SU, Song JM, Lee CM, Kim HA, Seong BL.
    Vaccine; 2006 Mar 10; 24(11):1966-74. PubMed ID: 16343703
    [Abstract] [Full Text] [Related]

  • 8. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.
    Vaccine; 2006 Nov 17; 24(47-48):6859-66. PubMed ID: 17050041
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC, Johansson BE.
    Virology; 2005 Sep 01; 339(2):273-80. PubMed ID: 15996702
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection.
    Okamoto S, Kawabata S, Fujitaka H, Uehira T, Okuno Y, Hamada S.
    Vaccine; 2004 Jul 29; 22(21-22):2887-93. PubMed ID: 15246625
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mucosal vaccination against influenza: protection of pigs immunized with inactivated virus and ether-split vaccine.
    Lim YK, Takada A, Tanizaki T, Ozaki H, Okazaki K, Kida H.
    Jpn J Vet Res; 2001 Feb 29; 48(4):197-203. PubMed ID: 11276584
    [Abstract] [Full Text] [Related]

  • 19. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
    Cox RJ, Hovden AO, Brokstad KA, Szyszko E, Madhun AS, Haaheim LR.
    Vaccine; 2006 Nov 10; 24(44-46):6585-7. PubMed ID: 16839650
    [Abstract] [Full Text] [Related]

  • 20. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Bungener L, Geeraedts F, Ter Veer W, Medema J, Wilschut J, Huckriede A.
    Vaccine; 2008 May 02; 26(19):2350-9. PubMed ID: 18400340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.